Lavipharm (ATH:LAVI) Days Sales Outstanding : 158.27 (As of Dec. 2023)

View and export this data going back to 1995. Start your Free Trial

What is Lavipharm Days Sales Outstanding?

Lavipharm's average Accounts Receivable for the six months ended in Dec. 2023 was €18.62 Mil. Lavipharm's Revenue for the six months ended in Dec. 2023 was €21.47 Mil. Hence, Lavipharm's Days Sales Outstanding for the six months ended in Dec. 2023 was 158.27.

The historical rank and industry rank for Lavipharm's Days Sales Outstanding or its related term are showing as below:

ATH:LAVI' s Days Sales Outstanding Range Over the Past 10 Years
Min: 112.63 Med: 138.23 Max: 153.24
Current: 129.9

During the past 7 years, Lavipharm's highest Days Sales Outstanding was 153.24. The lowest was 112.63. And the median was 138.23.

ATH:LAVI's Days Sales Outstanding is ranked worse than
85.44% of 996 companies
in the Drug Manufacturers industry
Industry Median: 71.41 vs ATH:LAVI: 129.90

Lavipharm's Days Sales Outstanding increased from Dec. 2022 (146.51) to Dec. 2023 (158.27).

Lavipharm Days Sales Outstanding Historical Data

The historical data trend for Lavipharm's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lavipharm Days Sales Outstanding Chart

Lavipharm Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

139.61

112.63

117.37

153.24

139.13

Lavipharm Semi-Annual Data
	Dec17	Dec18	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial					141.74	117.13	146.51	101.24	158.27

Competitive Comparison of Lavipharm's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Lavipharm's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lavipharm's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lavipharm's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Lavipharm's Days Sales Outstanding falls into.

Lavipharm Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Lavipharm's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (17.13	+	21.697)	/	2 )	/	50.929	*	365
=	19.4135					/	50.929	*	365
=	139.13

Lavipharm's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (15.549	+	21.697)	/	2 )	/	21.474	*	365 / 2
=	18.623					/	21.474	*	365 / 2
=	158.27

Lavipharm (ATH:LAVI) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Lavipharm Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Lavipharm's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Lavipharm (ATH:LAVI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lavipharm SA (ATH:LAVI) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

BXA0:Germany

Address

Agias Marinas Street, PO Box 59, Peania Attica, GRC, 19002

Website

http://www.lavipharm.com

Lavipharm SA develops, manufactures, markets and distributes pharmaceutical, cosmetic and consumer health products in Greece and internationally. The company's product portfolio includes innovative, safe and effective therapeutic solutions that meet consumer' needs for health and wellbeing. Its main product categories are Cardiology, Oncology, Urology, Neurology, Psychiatry, General Medicine, Self- Treatment and Dermocosmetic care.

Lavipharm (ATH:LAVI) Headlines

No Headlines